Selected research
Market Structure
Global Lactose-Free Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lactose-Free Infant Formula market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Lactose-Free Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lactose-Free Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lactose-Free Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lactose-Free Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lactose-Free Infant Formula include Mead Johnson, Abbott, Gerber, HIPP, Nestle, Vermont Organics, Perrigo Nutritionals, Earth's Best and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Lactose-Free Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lactose-Free Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lactose-Free Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lactose-Free Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.
Lactose-Free Infant Formula Segment by Company
Mead Johnson
Abbott
Gerber
HIPP
Nestle
Vermont Organics
Perrigo Nutritionals
Earth's Best
Bristol-Myers Squibb
Lactose-Free Infant Formula Segment by Type
Milk Infant Formula
Non-milk Infant Formula
Lactose-Free Infant Formula Segment by Application
Premature
Babies with galactosemia
Infants with Cow's Milk Protein Allergies
Others
Lactose-Free Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lactose-Free Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lactose-Free Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lactose-Free Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lactose-Free Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lactose-Free Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lactose-Free Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lactose-Free Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Milk Infant Formula
- Non-milk Infant Formula
Applications
- Premature
- Babies with galactosemia
- Infants with Cow's Milk Protein Allergies
- Others
Companies covered
- Mead Johnson
- Abbott
- Gerber
- HIPP
- Nestle
- Vermont Organics
- Perrigo Nutritionals
- Earth's Best
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Lactose-Free Infant Formula Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Lactose-Free Infant Formula Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Lactose-Free Infant Formula Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Lactose-Free Infant Formula Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Lactose-Free Infant Formula Market Dynamics
- 2.1 Lactose-Free Infant Formula Industry Trends
- 2.2 Lactose-Free Infant Formula Industry Drivers
- 2.3 Lactose-Free Infant Formula Industry Opportunities and Challenges
- 2.4 Lactose-Free Infant Formula Industry Restraints
3 Lactose-Free Infant Formula Market by Manufacturers
- 3.1 Global Lactose-Free Infant Formula Revenue by Manufacturers (2021-2026)
- 3.2 Global Lactose-Free Infant Formula Sales by Manufacturers (2021-2026)
- 3.3 Global Lactose-Free Infant Formula Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Lactose-Free Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lactose-Free Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Lactose-Free Infant Formula Manufacturers, Product Type & Application
- 3.7 Global Lactose-Free Infant Formula Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lactose-Free Infant Formula Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lactose-Free Infant Formula Players Market Share by Revenue in 2025
- 3.8.3 2025 Lactose-Free Infant Formula Tier 1, Tier 2, and Tier 3
4 Lactose-Free Infant Formula Market by Type
- 4.1 Lactose-Free Infant Formula Type Introduction
- 4.1.1 Milk Infant Formula
- 4.1.2 Non-milk Infant Formula
- 4.2 Global Lactose-Free Infant Formula Sales by Type
- 4.2.1 Global Lactose-Free Infant Formula Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Lactose-Free Infant Formula Sales by Type (2021-2032)
- 4.2.3 Global Lactose-Free Infant Formula Sales Market Share by Type (2021-2032)
- 4.3 Global Lactose-Free Infant Formula Revenue by Type
- 4.3.1 Global Lactose-Free Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Lactose-Free Infant Formula Revenue by Type (2021-2032)
- 4.3.3 Global Lactose-Free Infant Formula Revenue Market Share by Type (2021-2032)
5 Lactose-Free Infant Formula Market by Application
- 5.1 Lactose-Free Infant Formula Application Introduction
- 5.1.1 Premature
- 5.1.2 Babies with galactosemia
- 5.1.3 Infants with Cow's Milk Protein Allergies
- 5.1.4 Others
- 5.2 Global Lactose-Free Infant Formula Sales by Application
- 5.2.1 Global Lactose-Free Infant Formula Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Lactose-Free Infant Formula Sales by Application (2021-2032)
- 5.2.3 Global Lactose-Free Infant Formula Sales Market Share by Application (2021-2032)
- 5.3 Global Lactose-Free Infant Formula Revenue by Application
- 5.3.1 Global Lactose-Free Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Lactose-Free Infant Formula Revenue by Application (2021-2032)
- 5.3.3 Global Lactose-Free Infant Formula Revenue Market Share by Application (2021-2032)
6 Global Lactose-Free Infant Formula Sales by Region
- 6.1 Global Lactose-Free Infant Formula Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lactose-Free Infant Formula Sales by Region (2021-2032)
- 6.2.1 Global Lactose-Free Infant Formula Sales by Region (2021-2026)
- 6.2.2 Global Lactose-Free Infant Formula Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lactose-Free Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lactose-Free Infant Formula Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lactose-Free Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lactose-Free Infant Formula Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lactose-Free Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lactose-Free Infant Formula Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Lactose-Free Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Lactose-Free Infant Formula Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Lactose-Free Infant Formula Revenue by Region
- 7.1 Global Lactose-Free Infant Formula Revenue by Region
- 7.1.1 Global Lactose-Free Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Lactose-Free Infant Formula Revenue by Region (2021-2026)
- 7.1.3 Global Lactose-Free Infant Formula Revenue by Region (2027-2032)
- 7.1.4 Global Lactose-Free Infant Formula Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Lactose-Free Infant Formula Revenue (2021-2032)
- 7.2.2 North America Lactose-Free Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Lactose-Free Infant Formula Revenue (2021-2032)
- 7.3.2 Europe Lactose-Free Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Lactose-Free Infant Formula Revenue (2021-2032)
- 7.4.2 Asia-Pacific Lactose-Free Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Lactose-Free Infant Formula Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Lactose-Free Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Mead Johnson
- 8.1.1 Mead Johnson Company Information
- 8.1.2 Mead Johnson Business Overview
- 8.1.3 Mead Johnson Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Mead Johnson Lactose-Free Infant Formula Product Portfolio
- 8.1.5 Mead Johnson Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Lactose-Free Infant Formula Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Gerber
- 8.3.1 Gerber Company Information
- 8.3.2 Gerber Business Overview
- 8.3.3 Gerber Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Gerber Lactose-Free Infant Formula Product Portfolio
- 8.3.5 Gerber Recent Developments
- 8.4 HIPP
- 8.4.1 HIPP Company Information
- 8.4.2 HIPP Business Overview
- 8.4.3 HIPP Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 HIPP Lactose-Free Infant Formula Product Portfolio
- 8.4.5 HIPP Recent Developments
- 8.5 Nestle
- 8.5.1 Nestle Company Information
- 8.5.2 Nestle Business Overview
- 8.5.3 Nestle Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Nestle Lactose-Free Infant Formula Product Portfolio
- 8.5.5 Nestle Recent Developments
- 8.6 Vermont Organics
- 8.6.1 Vermont Organics Company Information
- 8.6.2 Vermont Organics Business Overview
- 8.6.3 Vermont Organics Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vermont Organics Lactose-Free Infant Formula Product Portfolio
- 8.6.5 Vermont Organics Recent Developments
- 8.7 Perrigo Nutritionals
- 8.7.1 Perrigo Nutritionals Company Information
- 8.7.2 Perrigo Nutritionals Business Overview
- 8.7.3 Perrigo Nutritionals Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Perrigo Nutritionals Lactose-Free Infant Formula Product Portfolio
- 8.7.5 Perrigo Nutritionals Recent Developments
- 8.8 Earth's Best
- 8.8.1 Earth's Best Company Information
- 8.8.2 Earth's Best Business Overview
- 8.8.3 Earth's Best Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Earth's Best Lactose-Free Infant Formula Product Portfolio
- 8.8.5 Earth's Best Recent Developments
- 8.9 Bristol-Myers Squibb
- 8.9.1 Bristol-Myers Squibb Company Information
- 8.9.2 Bristol-Myers Squibb Business Overview
- 8.9.3 Bristol-Myers Squibb Lactose-Free Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bristol-Myers Squibb Lactose-Free Infant Formula Product Portfolio
- 8.9.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Lactose-Free Infant Formula Value Chain Analysis
- 9.1.1 Lactose-Free Infant Formula Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Lactose-Free Infant Formula Production Mode & Process
- 9.2 Lactose-Free Infant Formula Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lactose-Free Infant Formula Distributors
- 9.2.3 Lactose-Free Infant Formula Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst